Search alternatives:
progress decrease » progressive decrease (Expand Search), problems decreased (Expand Search)
shape decrease » shape increases (Expand Search), step decrease (Expand Search), showed decreased (Expand Search)
small decrease » small increased (Expand Search)
progress decrease » progressive decrease (Expand Search), problems decreased (Expand Search)
shape decrease » shape increases (Expand Search), step decrease (Expand Search), showed decreased (Expand Search)
small decrease » small increased (Expand Search)
-
221
<sup>13</sup>C NMR spectra for Kylo-0603.
Published 2025Subjects: “…attenuates fibrosis progression…”
-
222
General procedure for the synthesis of A and A-c1.
Published 2025Subjects: “…attenuates fibrosis progression…”
-
223
Hematoxylin and eosin (H&E) staining, Sirius Red staining, and Oil Red staining of liver tissues from mice in each group after 8 weeks of treatment with either vehicle or Kylo-0603...
Published 2025Subjects: “…attenuates fibrosis progression…”
-
224
-
225
Trends of peroxisome-related gene expression in liver tissue.
Published 2025Subjects: “…attenuates fibrosis progression…”
-
226
NAS (NAFLD Activity Score) of liver tissue of mice in each group after 8 weeks of treatment with either vehicle (V) or Kylo-0603 (0.1-10 mg/kg/day).
Published 2025Subjects: “…attenuates fibrosis progression…”
-
227
The body weight and cholesterol levels of the mice were recorded before the administration of the drug.
Published 2025Subjects: “…attenuates fibrosis progression…”
-
228
Effect of Kylo-0603 drug on the reversal of steatosis and inhibition of fibrotic process in liver tissues of the MASH mouse models (F2 ~ 3), analyzed by SHG/TPEF microscopy combine...
Published 2025Subjects: “…attenuates fibrosis progression…”
-
229
-
230
-
231
-
232
General procedure for the synthesis of Kylo-0603.
Published 2025Subjects: “…attenuates fibrosis progression…”
-
233
-
234
-
235
-
236
-
237
-
238
-
239
-
240